Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 17 citing articles:

Alternatives Therapeutic Approaches to Conventional Antibiotics: Advantages, Limitations and Potential Application in Medicine
Hiba Alaoui Mdarhri, Rachid Benmessaoud, Houda Yacoubi, et al.
Antibiotics (2022) Vol. 11, Iss. 12, pp. 1826-1826
Open Access | Times Cited: 70
Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia: a systematic review and meta-analysis
Stamatis Karakonstantis, Maria Rousaki, Loukia Vassilopoulou, et al.
Clinical Microbiology and Infection (2023) Vol. 30, Iss. 2, pp. 178-188
Open Access | Times Cited: 50
Global trends of ceftazidime–avibactam resistance in gram-negative bacteria: systematic review and meta-analysis
Yang Wang, Mohammad Sholeh, Ling Yang, et al.
Antimicrobial Resistance and Infection Control (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program
Michael J. Satlin, Patricia J. Simner, Christine M Slover, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 7
Open Access | Times Cited: 24
Cefiderocol Efficacy in a Real-Life Setting: Single-Centre Retrospective Study
Gabriele Palermo, Alice Annalisa Medaglia, Luca Pipitò, et al.
Antibiotics (2023) Vol. 12, Iss. 4, pp. 746-746
Open Access | Times Cited: 13
Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy
M. Montero, Sandra Domene-Ochoa, Núria Prim, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2025)
Open Access
In vitro activity of cefiderocol and comparator antibiotics against multidrug-resistant non-fermenting Gram-negative bacilli
Yu‐Shan Huang, Yu‐Chung Chuang, Pao-Yu Chen, et al.
JAC-Antimicrobial Resistance (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 6
In Vivo Development of Aztreonam Resistance in Meropenem-Resistant Pseudomonas aeruginosa Owing to Overexpression of the bla PDC-16
Li Ding, Yue Sun, Yizhuo Zhang, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 4
Abundant diversity of accessory genetic elements and associated antimicrobial resistance genes in pseudomonas aeruginosa isolates from a single Chinese hospital
Xiaofei Mu, Xinyue Li, Zhe Yin, et al.
Annals of Clinical Microbiology and Antimicrobials (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Phenotypic and genotypic detection of Beta-lactamase producing Pseudomonas aeruginosa isolated from Haryana, India
Khem Chand, Amit Lath, Aparna Yadav, et al.
Journal of Applied Biology & Biotechnology (2024)
Open Access | Times Cited: 1
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia
Stephanie L Egge, James S. Lewis, Morgan Hakki
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 8
Open Access | Times Cited: 2
Genetic Characteristics of Novel IncpSE5381-aadB Plasmids, Integrative and Mobilizable Elements, and Integrative and Conjugative Elements in Pseudomonas aeruginosa
Jiaqi He, Xiuhui Lu, Chenchen Yuan, et al.
Infection and Drug Resistance (2024) Vol. Volume 17, pp. 2053-2068
Open Access
In vivo divergent evolution of cross-resistance to new β-lactam/β-lactamase inhibitor combinations in Pseudomonas aeruginosa following ceftazidime/avibactam treatment
Heng Cai, Minhua Chen, Yue Li, et al.
Infection (2024)
Closed Access
Antimicrobial resistance profile, biofilm forming capacity and associated factors of multidrug resistance in Pseudomonas aeruginosa among patients admitted at Tikur Anbessa Specialized Hospital and Yekatit 12 Hospital Medical College in Addis Ababa, Ethiopia
Matifan Dereje Olana, Daniel Asrat, Göte Swedberg
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access
Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical management
M. Montero, Juan Pablo Horcajada
Enfermedades infecciosas y microbiologia clinica (English ed ) (2023) Vol. 41, Iss. 8, pp. 451-453
Closed Access | Times Cited: 1
Multidrug-resistant Pseudomonas aeruginosa: A pathogen with challenging clinical management
M. Montero, Juan Pablo Horcajada
Enfermedades Infecciosas y Microbiología Clínica (2023) Vol. 41, Iss. 8, pp. 451-453
Closed Access
Resistance Genes and Molecular Epidemiology in Ceftazidime-Avibactam-Resistant Pseudomonas aeruginosa Isolates
Neslihan Arıcı, Elif Seren Tanrıverdi
Mediterranean Journal of Infection Microbes and Antimicrobials (2023)
Open Access
Page 1

Scroll to top